Psycho-education & Understanding Bipolar Medications Therapy + MBSR + ISRT + Bipolar-Specific CBT for Bipolar Disorder
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how different therapies can improve the lives of people with Bipolar Disorder by reducing suicidal behavior. It includes a 6-week group-based program featuring treatments such as Cognitive Behavioral Therapy (CBT) tailored for bipolar disorder, Mindfulness-Based Stress Reduction (MBSR), Interpersonal and Social Rhythm Therapy (ISRT), and education about bipolar medications. The trial aims to understand the environmental and psychological factors influencing suicidality and to identify effective treatment methods. English-speaking individuals diagnosed with Bipolar Disorder, who are not experiencing other severe mental health issues, may be suitable candidates for this trial. As an unphased trial, it offers a unique opportunity to contribute to groundbreaking research that could enhance treatment options for Bipolar Disorder.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that Bipolar-Specific Cognitive Behavioral Therapy (CBT) is safe and well-tolerated for people with bipolar disorder. It helps manage symptoms without causing major side effects and is recommended as an additional therapy alongside regular treatment.
Studies have found that Interpersonal and Social Rhythm Therapy (ISRT) is also safe and practical for those with bipolar disorder. Participants have found it helpful in maintaining regular social routines, which can improve mood stability.
Mindfulness-Based Stress Reduction (MBSR) is a promising option for treating mood issues, including those related to bipolar disorder. Research suggests it can reduce symptoms of depression and anxiety without causing significant side effects.
Psycho-education and Understanding Bipolar Medications Therapy focuses on teaching patients about their condition and treatment options. This therapy is generally safe, as it involves sharing information rather than taking new medication or undergoing risky procedures.
Overall, these therapies have demonstrated good safety profiles in research, making them promising for individuals considering participation in a clinical trial to help manage bipolar disorder symptoms.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it combines several innovative therapeutic techniques specifically tailored for individuals with Bipolar Disorder. Unlike typical treatments that often focus solely on medication, this approach integrates Bipolar-Specific Cognitive Behavioral Therapy (CBT), Interpersonal and Social Rhythm Therapy (ISRT), Mindfulness-Based Stress Reduction (MBSR), and psycho-education, offering a comprehensive strategy that addresses both emotional regulation and lifestyle management. This holistic approach aims to improve patients' understanding and management of their condition by fostering stability in daily rhythms, enhancing mindfulness, and providing targeted psychological support. By combining these elements, researchers hope to offer more effective and personalized care, potentially leading to better outcomes for those with Bipolar Disorder.
What evidence suggests that this trial's treatments could be effective for Bipolar Disorder?
Research has shown that Bipolar-Specific Cognitive Behavioral Therapy (CBT) can lower depression and mania while improving daily life skills. However, its effectiveness without medication remains uncertain. Interpersonal and Social Rhythm Therapy (ISRT) has boosted mood and reduced symptoms in people with bipolar disorder. Mindfulness-Based Stress Reduction (MBSR) can ease depression and anxiety by helping patients manage their emotions better. Additionally, Psycho-education and Understanding Bipolar Medications Therapy can help individuals adhere to their medication plans and improve overall well-being. In this trial, participants will receive a combination of these therapies in a group intervention program. Each treatment has shown promise in enhancing the quality of life for those with bipolar disorder.12678
Who Is on the Research Team?
Dorian Lamis, PhD
Principal Investigator
Emory University
Are You a Good Fit for This Trial?
This trial is for English-speaking individuals with Bipolar Disorder who can consent to participate. It's not suitable for those with cognitive impairments, organic diseases, dementia, severe substance disorders, acute psychosis, or schizophrenia spectrum disorders.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo a 6-week group-based intervention program focusing on interpersonal/social rhythm, mindfulness, and cognitive interventions to cope with Bipolar Depression
Follow-up
Participants are monitored for changes in depressive symptoms, mania, quality of life, aggression, interpersonal needs, and suicide ideation
What Are the Treatments Tested in This Trial?
Interventions
- Bipolar-Specific Cognitive Behavioral Therapy (CBT)
- Interpersonal and Social Rhythm Therapy (ISRT)
- Mindfulness-Based Stress Reduction (MBSR)
- Psycho-education & Understanding Bipolar Medications Therapy
Bipolar-Specific Cognitive Behavioral Therapy (CBT) is already approved in United States, European Union, Canada for the following indications:
- Bipolar Disorder
- Suicidal Behavior in Bipolar Disorder
- Bipolar Disorder
- Mood Stabilization
- Bipolar Disorder
- Suicidal Behavior
Find a Clinic Near You
Who Is Running the Clinical Trial?
Emory University
Lead Sponsor